RT Journal Article
SR Electronic
T1 Tumor Necrosis Factor-α Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 946
OP 948
DO 10.3899/jrheum.111093
VO 39
IS 5
A1 BILI, ANDRONIKI
A1 MORRIS, STEPHANIE J.
A1 SARTORIUS, JENNIFER A.
A1 KIRCHNER, H. LES
A1 ANTOHE, JANA L.
A1 DANCEA, SORINA
A1 WASKO, MARY CHESTER
YR 2012
UL http://www.jrheum.org/content/39/5/946.abstract
AB Objective. To determine the association of use of tumor necrosis factor-α (TNF-α) inhibitors with differences in lipid levels in patients with rheumatoid arthritis (RA). Methods. We studied 807 patients with incident RA to compare differences in lipid levels in TNF-α inhibitor users versus nonusers, with adjustment for relevant covariables. Results. TNF-α inhibitor use was not associated with differences in levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), triglycerides, LDL:HDL, or TC:HDL compared to nonusers. Conclusion. Use of TNF-α inhibitor was not associated with differences in lipid levels in patients with RA.